{"altmetric_id":736719,"counts":{"readers":{"mendeley":5,"citeulike":0,"connotea":0},"total":{"posts_count":2},"twitter":{"unique_users_count":2,"unique_users":["bbbrieger","ABM_GH"],"posts_count":2}},"selected_quotes":["thinking beyond a single disease in mass treatment programs -"],"citation":{"altmetric_jid":"4f6fa4ea3cf058f61000255e","doi":"10.1093\/cid\/cis241","first_seen_on":"2012-05-10T12:08:25+00:00","funders":["niaid","phs"],"issns":["1537-6591"],"journal":"Clinical Infectious Diseases","last_mentioned_on":1336663507,"links":["http:\/\/cid.oxfordjournals.org\/content\/54\/11\/1674.extract"],"pdf_url":"http:\/\/cid.oxfordjournals.org\/content\/54\/11\/1674.full.pdf","pmid":"22431805","pubdate":"2012-01-01T00:00:00+00:00","publisher_subjects":[{"name":"Biological Sciences","scheme":"era"},{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["communicablediseases"],"title":"Thinking Deeper About Important Mass Treatment Trials","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/thinking-deeper-about-important-mass-treatment-trials"},"altmetric_score":{"score":1.1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1.1},"context_for_score":{"all":{"total_number_of_other_articles":4989044,"mean":5.9006347369662,"rank":2624235,"this_scored_higher_than_pct":46,"this_scored_higher_than":2342221,"rank_type":"exact","sample_size":4989044,"percentile":46},"similar_age_3m":{"total_number_of_other_articles":78445,"mean":4.8259382744378,"rank":34779,"this_scored_higher_than_pct":55,"this_scored_higher_than":43293,"rank_type":"exact","sample_size":78445,"percentile":55},"this_journal":{"total_number_of_other_articles":5546,"mean":6.3748934174932,"rank":3400,"this_scored_higher_than_pct":38,"this_scored_higher_than":2135,"rank_type":"exact","sample_size":5546,"percentile":38},"similar_age_this_journal_3m":{"total_number_of_other_articles":87,"mean":3.9769069767442,"rank":49,"this_scored_higher_than_pct":43,"this_scored_higher_than":38,"rank_type":"exact","sample_size":87,"percentile":43}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":2}},"mendeley":{"by_status":{"Researcher":2,"Student  > Ph. D. Student":1,"Other":1,"Student  > Master":1},"by_discipline":{"Medicine and Dentistry":1,"Psychology":1,"Agricultural and Biological Sciences":2,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"GH":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/#!\/bbbrieger\/status\/200556091665420289","citation_ids":[736719],"posted_on":"2012-05-10T12:01:13+00:00","author":{"name":"Bill Tropical Health","url":"http:\/\/malariamatters.org\/","image":"https:\/\/pbs.twimg.com\/profile_images\/515162872872042496\/yBsATrMz_normal.jpeg","description":"Malaria, NTDs, Ebola, Health Systems, Atunluse, Otun Ba'asegun","id_on_source":"bbbrieger","tweeter_id":"106810410","geo":{"lt":null,"ln":null},"followers":2960},"tweet_id":"200556091665420289"},{"url":"http:\/\/twitter.com\/#!\/ABM_GH\/status\/200607406739304448","rt":["bbbrieger"],"citation_ids":[736719],"posted_on":"2012-05-10T15:25:07+00:00","author":{"name":"Ali Bukari Maiga","url":"http:\/\/t.co\/tZYlxw7o3k","image":"http:\/\/a0.twimg.com\/profile_images\/3776945095\/d9a3c2730ee025a1c2b30f4637d5784a_normal.jpeg","description":"FOLLOW EXCELLENCE......SUCCESS WILL CHASE YOU....! #TeamManUnited #Gemini Change!!!","id_on_source":"ABM_GH","tweeter_id":"297586752","geo":{"lt":5.63407,"ln":0.0074,"country":"GH"},"followers":316},"tweet_id":"200607406739304448"}]}}